BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8779690)

  • 1. Human heart endothelial-cell-restricted allorecognition.
    Jutte NH; Knoop CJ; Heijse P; Balk AH; Mochtar B; Claas FH; Weimar W
    Transplantation; 1996 Aug; 62(3):403-6. PubMed ID: 8779690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity of graft-derived lymphocytes: specific for donor heart endothelial cells?
    Jutte NH; Knoop CJ; Heijse P; Balk AH; Mochtar B; Claas FH; Weimar W
    J Heart Lung Transplant; 1997 Feb; 16(2):209-15. PubMed ID: 9059932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of antiviral and allogeneic activity of a human public CTL clonotype by a single altered peptide ligand: implications for allograft rejection.
    Ely LK; Green KJ; Beddoe T; Clements CS; Miles JJ; Bottomley SP; Zernich D; Kjer-Nielsen L; Purcell AW; McCluskey J; Rossjohn J; Burrows SR
    J Immunol; 2005 May; 174(9):5593-601. PubMed ID: 15843558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single minor histocompatibility antigen encoded by UGT2B17 and presented by human leukocyte antigen-A*2902 and -B*4403.
    Terakura S; Murata M; Warren EH; Sette A; Sidney J; Naoe T; Riddell SR
    Transplantation; 2007 May; 83(9):1242-8. PubMed ID: 17496542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease.
    Burrows SR; Khanna R; Burrows JM; Moss DJ
    J Exp Med; 1994 Apr; 179(4):1155-61. PubMed ID: 7511682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
    Bishop DK; Shelby J; Eichwald EJ
    Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic T lymphocytes infiltrating the human cardiac allograft show a restriction in T-cell receptor V beta gene usage: a study on serial biopsy and blood specimens.
    Hu H; de Jonge N; Doornewaard H; Gmelig-Meyling FH; Tilanus MG; Bosboom K; Robertus M; Plomp S; van Reijsen FC; Laphor JR
    J Heart Lung Transplant; 1994; 13(6):1058-71. PubMed ID: 7865513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and molecular mechanisms of human cardiac myocyte injury after transplantation.
    Ansari AA; Sundstrom JB; Kanter K; Mayne A; Villinger F; Gravanis MB; Herskowitz A
    J Heart Lung Transplant; 1995; 14(1 Pt 1):102-12. PubMed ID: 7727458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of peptide involvement in T cell allorecognition using recombinant HLA class I multimers.
    Whitelegg AM; Oosten LE; Jordan S; Kester M; van Halteren AG; Madrigal JA; Goulmy E; Barber LD
    J Immunol; 2005 Aug; 175(3):1706-14. PubMed ID: 16034111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial and smooth muscle cells in the heart allograft response: isolation procedure and immunocytochemical features.
    Wijngaard PL; de Bresser JM; de Groot PG; Gmelig-Meyling FH; Schuurman HJ; Jambroes G; Borleffs JC
    J Heart Lung Transplant; 1991; 10(3):416-23. PubMed ID: 1830221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered specificity of alloreactive cardiac graft-infiltrating cells by prophylactic treatment with OKT3 or horse antilymphocyte globulin.
    Ouwehand AJ; Baan CC; Groeneveld K; Balk AH; Jutte NH; Bos E; Claas FH; Weimar W
    Transplantation; 1993 Jan; 55(1):154-8. PubMed ID: 8420041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor heart endothelial cells as targets for graft infiltrating lymphocytes after clinical cardiac transplantation.
    Jutte NH; Heijse P; van Batenburg MH; Vaessen LM; Mochtar B; Balk AH; Claas FH; Weimar W
    Transpl Immunol; 1993; 1(1):39-44. PubMed ID: 8081761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine messenger RNA expression by donor-specific cytotoxic T-cell clones after allogeneic heart transplantation.
    Van Hoffen E; Gmelig-Meyling FH; Bosboom-Kalsbeek KC; Hu H; De Jonge N; Tilanus MG; Lahpor JR; De Weger RA
    J Heart Lung Transplant; 1997 Feb; 16(2):216-21. PubMed ID: 9059933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsies.
    Frank R; Dean SA; Molina MR; Kamoun M; Lal P
    Cardiovasc Pathol; 2015; 24(3):168-72. PubMed ID: 25440957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of breast cancer-associated peptides by tumor-reactive, HLA-class I restricted allogeneic cytotoxic T lymphocytes.
    Nguyen T; Naziruddin B; Dintzis S; Doherty GM; Mohanakumar T
    Int J Cancer; 1999 May; 81(4):607-15. PubMed ID: 10225452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial- and endothelial-cell specificity of renal graft infiltrating T cells.
    Deckers JG; Daha MR; Van der Kooij SW; Van der Woude FJ
    Clin Transplant; 1998 Aug; 12(4):285-91. PubMed ID: 9686321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different patterns in donor-specific production of T-helper 1 and 2 cytokines by cells infiltrating the rejecting cardiac allograft.
    van Besouw NM; Daane CR; Vaessen LM; Balk AH; Claas FH; Zondervan PE; Jutte NH; Weimar W
    J Heart Lung Transplant; 1995; 14(5):816-23. PubMed ID: 8800715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysis of heart endothelial cells from donor origin by cardiac graft infiltrating cells.
    Jutte NH; van Batenburg MH; Daane CR; Heijse P; Vaessen LM; Balk AH; Mochtar B; Claas FH; Weimar W
    Transpl Int; 1992; 5 Suppl 1():S645-7. PubMed ID: 14621898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes.
    Brichard VG; Herman J; Van Pel A; Wildmann C; Gaugler B; Wölfel T; Boon T; Lethé B
    Eur J Immunol; 1996 Jan; 26(1):224-30. PubMed ID: 8566071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactivity of self-HLA-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes for allo-HLA determinants.
    Gaston JS; Rickinson AB; Epstein MA
    J Exp Med; 1983 Dec; 158(6):1804-21. PubMed ID: 6196431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.